282 related articles for article (PubMed ID: 24716927)
21. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
22. Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Gehlot P; Shukla V; Gupta S; Makidon PE
J Transl Med; 2016 Feb; 14():49. PubMed ID: 26873175
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients.
Izycka N; Rucinski M; Andrzejewska M; Szubert S; Nowak-Markwitz E; Sterzynska K
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768723
[TBL] [Abstract][Full Text] [Related]
26. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
28. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
29. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
[TBL] [Abstract][Full Text] [Related]
30. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M
Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
[TBL] [Abstract][Full Text] [Related]
33. Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.
Seo AN; Lee HJ; Kim EJ; Jang MH; Kim YJ; Kim JH; Kim SW; Ryu HS; Park IA; Im SA; Gong G; Jung KH; Kim HJ; Park SY
Br J Cancer; 2016 May; 114(10):1109-16. PubMed ID: 27115469
[TBL] [Abstract][Full Text] [Related]
34. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
[TBL] [Abstract][Full Text] [Related]
35. GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
Inoue R; Hirohashi Y; Kitamura H; Nishida S; Murai A; Takaya A; Yamamoto E; Matsuki M; Tanaka T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Sato N; Masumori N; Torigoe T
Oncotarget; 2017 Apr; 8(17):28826-28839. PubMed ID: 28418868
[TBL] [Abstract][Full Text] [Related]
36. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
37. Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.
Isfoss BL; Busch C; Hermelin H; Vermedal AT; Kile M; Braathen GJ; Majak B; Berner A
Virchows Arch; 2014 Apr; 464(4):473-88. PubMed ID: 24570393
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem cell markers in intraoral minor salivary gland tumors.
Yıldırım B; Shuibat A
Pol J Pathol; 2022; 73(1):34-42. PubMed ID: 35848479
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of ALDH1 and CD44 positivity for radiotherapy response and prognosis in early-stage glottic laryngeal squamous cell carcinoma.
Surmelioglu O; Erdogan K; Dagkiran M; Ozdemir S; Tarkan O; Uguz A
Pol J Pathol; 2022; 73(1):43-49. PubMed ID: 35848480
[TBL] [Abstract][Full Text] [Related]
40. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
